PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS

A NON-CANONICAL SIGNALING ACTIVITY OF CGAMP TRIGGERS DNA DAMAGE RESPONSE SIGNALING

ANTISENSE OLIGONUCLEOTIDES TARGETING UNC13A

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL

GALNAC-MONOMERS AND GALNAC-NUCLEIC ACID CONJUGATES

COMPOSITIONS COMPRISING DOPED SILICON PARTICLES, AND RELATED METHODS

NOVEL THERAPEUTIC DELIVERY MOIETIES AND USES THEREOF

MODULATORS OF ENaC EXPRESSION

MODIFIED OLIGONUCLEOTIDES TARGETING SNPs

METHODS FOR REACTIVATING GENES ON THE INACTIVE X CHROMOSOME

LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF SERUM AMYLOID A GENE

NUCLEIC ACID CONSTRUCT ENABLING EXPRESSION AND INHIBITION OF GENE SIMULTANEOUSLY

CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC

BLOCK COPOLYMERS

Therapeutic Compounds for Inhibiting and Reducing the Expression of Cell Surface Proteins

TOPICAL DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES

CELLULAR THERAPIES FOR CANCER BY INHIBITION OF MONOCARBOXYLATE TRANSPORTER 11

COMPOSITIONS AND METHODS FOR TREATMENT OF GAUCHER DISEASE

NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, AND PREPARATION METHOD AND USE

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERY OF MRNA AND LONG NUCLEIC ACIDS

METHOD FOR RNAI FUNGICIDE GENERATING AND THE RNAI FUNGICIDE THEREOF

PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Multi-Valent Oligonucleotide Agent and Methods of Use Thereof

METHOD FOR PRODUCING DIRECTLY REPROGRAMMED NATURAL KILLER CELLS AND USES THEREOF

NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS

COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS

MITOCHONDRIAL SUPERCOMPLEX FORMATION PROMOTER, COMPOSITION FOR MAINTAINING OR IMPROVING MUSCULAR STRENGTH, THERAPEUTIC OR PREVENTATIVE PHARMACEUTICAL COMPOSITION FOR DISEASES WHICH DECREASE MITOCHONDRIAL FUNCTION OR MUSCULAR FUNCTION, AND SCREENING METHOD FOR SUBSTANCES WHICH CONTRIBUTE TO FORMATION OF MITOCHONDRIAL SUPERCOMPLEX

ANTI-FIBROSIS PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

TRACKING APOBEC MUTATIONAL SIGNATURES IN TUMOR CELLS

COMPOSITIONS AND METHODS FOR INHIBITING TRANSMEMBRANE SERINE PROTEASE 6 (TMPRSS6) EXPRESSION

TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE

INVERTED CHIMERIC siRNA MOLECULES AND METHODS OF USE THEREOF

SMALL INTERFERING RNA TARGETING HBV AND USES THEREOF

COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

CTLA-4 APTAMER CONJUGATES

DOUBLE-STRANDED OLIGONUCLEOTIDE, COMPOSITION AND CONJUGATE CONTAINING DOUBLE-STRANDED OLIGONUCLEOTIDE, AND PREPARATION METHODS AND USES

STABILIZATION OF OLIGONUCLEOTIDE AND OLIGONUCLEOTIDE-PROTEIN COMPLEX USING ALKYLATED PHOSPHATE

METHODS AND COMPOSITIONS TO DIAGNOSE AND TREAT TAUOPATHIES UTILIZING TRANSCRIPT VARIANTS OF PSEN2

METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

USE OF A LRP1 INHIBITOR IN TREATING NOTCH SIGNALING-DEPENDENT DISEASE

Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell Transfer

METHODS AND COMPOSITIONS FOR CANCER TREATMENT BY TARGETING AXL SIGNALING

CHEMICALLY MODIFIED OLIGONUCLEOTIDES

LEUCINE-RICH REPEAT KINASE 2 (LRRK2) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER

UNA AMIDITES AND USES THEREOF

OLIGONUCLEOTIDES FOR HTT-1A MODULATION

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

OLIGONUCLEOTIDE CONJUGATES TARGETED TO THE TRANSFERRIN RECEPTOR

NATURAL KILLER CELLS ENGINEERED TO REDUCE OR ELIMINATE CBL-B AND USES THEREOF

AGENT FOR USE IN THE TREATMENT OF GLIOMA

NOVEL REDOX-BASED THERAPEUTIC APPROACH FOR TREATMENT OF CANCER

METHODS AND COMPOSITIONS TO TREAT HUNTINGTON'S DISEASE BY TARGETING ALOX5- MEDIATED FERROPTOSIS

LIPID NANOPARTICLES AND METHOD FOR PREPARING SAME

METHOD FOR IMPROVING GENETIC ENGINEERING OF ADOPTIVE CELL THERAPIES

Method of Treatment for Auditory Dysfunction

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING POMPE DISEASE

MODULATION OF NOX4 EXPRESSION

FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALING

COMPLEMENT COMPONENT C3 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

SELECTIVE DELIVERY OF OLIGONUCLEOTIDES TO GLIAL CELLS

ENGINEERED NATURAL KILLER (NK) CELLS AND COMPOSITIONS AND METHODS THEREOF

CHLORELLA-BASED PRODUCTION OF EXTRACELLULAR VESICLE-EMBEDDED SMALL RNAS FOR BIOCONTROL APPLICATIONS

COMPOSITIONS AND METHODS FOR MODULATING CANCER IMMUNE FITNESS

COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO

Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of use thereof to target dystrophin and to treat Duchenne muscular dystrophy

CARBOHYDRATE CONJUGATES FOR THE DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES

BRANCHED OLIGONUCLEOTIDES

METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

CONTROL OF PLANT PESTS USING RNA MOLECULES

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC OLIGONUCLEOTIDES TO THE CENTRAL NERVOUS SYSTEM

COMPOSITIONS AND METHODS FOR TREATING CANCER

GLUCOKINASE (GCK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS

TREATMENT OF MTRES1 RELATED DISEASES AND DISORDERS

TREATMENT OF PLIN1 RELATED DISEASES AND DISORDERS

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (SINA)

OLIGONUCLEOTIDES FOR IFN-GAMMA SIGNALING PATHWAY MODULATION

THERAPEUTIC AGENT FOR MUSCULAR ATROPHY

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS

Compositions And Methods For Enhancing Immunotherapy

COMPOSITIONS AND METHODS OF TREATING DISEASES ASSOCIATED WITH BILE ACID TRANSPORTER

TREATMENT OF ANGPTL4 RELATED DISEASES

HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL

Methods and Compositions for Managing Vascular Conditions Using miR-483 Mimics and HIF1alpha Pathway Inhibitors

DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO

LIGAND-BINDING NUCLEIC ACID COMPLEX

FOLLICULIN iRNA COMPOSITIONS AND METHODS THEREOF

RNAi AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES

METHOD FOR IMMORTALISING VESICLE-SECRETING CELLS

METHODS AND COMPOSITIONS FOR MODIFYING MACROPHAGE POLARIZATION INTO PRO-INFLAMMATORY CELLS TO TREAT CANCER

CD71 BINDING FIBRONECTIN TYPE III DOMAINS

SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

POLYNUCLEIC ACID MOLECULES TARGETING PCSK9 AND USES THEREOF

COMPOSITIONS AND METHODS FOR THE INHIBITION OF NERVE GROWTH FACTOR AND THE TREATMENT/PREVENTION OF ATRIAL FIBRILLATION

COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF HEPATITIS B VIRUS (HBV)PROTEIN

METHODS AND COMPOSITIONS FOR MODULATING STING SIGNALING AND INNATE IMMUNE RESPONSES

Asymmetric Short Duplex DNA as a Novel Gene Silencing Technology and Use Thereof

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

KRAB-Containing Zinc Finger Protein And Cancer

METHODS AND COMPOSITIONS FOR CELL REPROGRAMMING

COMPOSITIONS AND METHODS FOR TRANSGENE EXPRESSION

NANOPARTICLE COMPRISING PEPTIDE-LIPID CONJUGATE FOR DELIVERING OLIGONUCLEOTIDE INTO TARGET CELL AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS

COMPOSITION FOR TREATING METASTATIC SOLID CANCER, COMPRISING TSG6 INHIBITOR

MODULAR LIPID COMPOUNDS AND TWO- TO THREE-COMPONENT LIPID NANOPARTICLE COMPOSITIONS

SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT

Methods and Compositions for Determining pH

COMPOSITIONS AND METHODS FOR SILENCING CARBONIC ANHYDRASE 2 EXPRESSION

BETA-CATENIN (CTNNB1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Short Duplex DNA as a Novel Gene Silencing Technology and Use Thereof

COMPOSITIONS AND METHODS OF TARGETING THE PAX6 SIGNALING PATHWAY TO REDUCE FORMATION OF AMYLOID BETA PLAQUES AND NEUROFIBRILLARY TANGLES

MICROTUBULE ASSOCIATED PROTEIN TAU (MAPT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

SIRNAS TARGETING SLC10A1 TRANSCRIPTS, COMPOSITIONS AND USES THEREOF

METHODS FOR TREATING OR PREVENTING CONTACT-ACTIVATION PATHWAY-ASSOCIATED DISEASES USING iRNA COMPOSITIONS TARGETING FACTOR XII (HAGEMAN FACTOR) (F12)

RABIES VIRAL GLYCOPROTEIN COMPOSITIONS AND METHODS OF USE

PRE-IMMUNIZATION AND IMMUNOTHERAPY

COMPOSITIONS AND METHODS FOR PROMOTING THE MINERALIZATION OF BIOLOGICAL TISSUE

FATTY ACID CONJUGATES OF NUCLEIC ACIDS

RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

Treatment Of Stroke With 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Inhibitors

METHODS AND COMPOSITIONS FOR TREATING AN ANGIOTENSINOGEN- (AGT-) ASSOCIATED DISORDER

POLYNUCLEOTIDE CONSTRUCTS

CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF

TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS

METHODS OF USING USP15 INHIBITORS

COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS

INHIBITORS OF MITOFERRIN-2 FOR USE IN TREATING CANCER

HOST FACTORS THAT ENHANCE VIRAL PRODUCTION VIA VIRALLY DRIVEN FITNESS-BASED CRISPR SCREENING

HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

SIRNA CONSTRUCTS FOR INHIBITING GENE EXPRESSION IN TARGETED CANCER CELLS

MULTITARGETING RNA COMPOSITIONS

PREVENTION OR TREATMENT OF MYOPATHY USING MIR-33B INHIBITOR

Muscle targeting complexes and uses thereof for treating myotonic dystrophy

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

IN-SITU CRYO-IMMUNE ENGINEERING FOR CANCER IMMUNOTHERAPY

METHODS OF TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS

Methods and Compositions for Treating, Ameliorating, and/or Preventing Chronic Kidney Disease (CKD) and Complications thereof by Regulating DPEP1, CASP9, ACSS2 and/or FASN

ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES

LIPID NANOPARTICLES AND METHODS OF USE

Compositions for Inhibiting Growth of Targeted Cells

Multitargeting RNA Immunotherapy Compositions

COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA

NUCLEIC ACID DELIVERY SYSTEM AND APPLICATION THEREOF

CHIRAL CONTROL

siRNA AND USE THEREOF

VON WILLEBRAND FACTOR (VWF) INHIBITORS

TM4SF19 INHIBITOR AND USES THEREOF

METHODS AND COMPOSITIONS FOR REDUCING NUCLEIC ACID VECTOR-INDUCED TOXICITY IN THE INNER EAR

COMPOSITION FOR TREATING OSTEOARTHRITIS

METHOD OF TREATING BREAST CANCER IN A SUBJECT BY INHIBITING TUBB2B

COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS

COLON CANCER-SPECIFIC TARGET EXOSOME COMPOSITION AS DRUG DELIVERY MATERIAL, AND USE THEREOF

REPROGRAMMING OF NON-NEURONAL CELLS INTO NEURONS AND METHODS AND COMPOSITIONS TO TREAT NEURODEGENERATIVE DISEASES AND DISORDERS

CHITOSAN-CONTAINING NANOPARTICLES FOR DELIVERY OF POLYNUCLEOTIDES

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS

COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-beta

METHOD OF TREATING BREAST CANCER IN A SUBJECT BY INHIBITING TUBB2B

INHIBITOR OF SUV39H1 HISTONE METHYLTRANSFERASE FOR USE IN CANCER COMBINATION THERAPY

METHODS AND USES OF PROTEIN DISULFIDE ISOMERASE INHIBITORY COMPOUNDS

iRNA COMPOSITIONS AND METHODS FOR SILENCING CHITINASE 3-LIKE PROTEIN 1/YKL-40 (CHI3L1/YKL-40) PROTEIN

ELONGATION OF VERY LONG CHAIN FATTY ACIDS PROTEIN 1 (ELOVL1) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

METHODS OF MODULATING ALK

INHIBITORY NUCLEIC ACIDS FOR FACTOR H FAMILY PROTEINS

DNA CONSTRUCTS COMPRISING ALTERNATIVE PROMOTERS

TARGETING PIEZO1 TO TREAT INHERITED AND AGE-RELATED MACULAR DEGENERATIONS

ORAL DELIVERY OF OLIGONUCLEOTIDES

SUBSTRATE SEQUENCE DESIGN WORKFLOW FOR THE RNAI-MEDIATED MULTI-SITE REGULATION OF GENOMIC AND SUB-GENOMIC VIRAL RNAS

METHODS OF DETECTING AND REDUCING CANCER CELL CENTRAL NERVOUS SYSTEM COLONIZATION

USE OF ODORANT RECEPTOR FOR SUPPRESSING LACTATE-INDUCED M2-TYPE DIFFERENTIATION OF TUMOR-ASSOCIATED MACROPHAGES AND TUMOR GROWTH

NUCLEIC ACID MOLECULE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE

DIAGNOSTIC DEVICE FOR LOCAL INTRAVENOUS BIOMARKER MEASUREMENTS AND METHODS OF USE THEREOF

Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors

STEAROYL-COA DESATURASE 5 (SCD5) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION, CONJUGATE, PREPARATION METHOD, AND USE

ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHOD AND COMPOSITIONS FOR PREVENTING TUMOR DEVELOPMENT AND METASTASIS

MICROGLIAL GENE SILENCING USING DOUBLE-STRANDED SIRNA

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION, CONJUGATE, PREPARATION METHOD, AND USE

TISSUE-SPECIFIC NUCLEIC ACID DELIVERY BY MIXED CATIONIC LIPID PARTICLES

DEFINED MULTI-CONJUGATES OLIGONUCLEOTIDES

BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS

ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION

CONJUGATES OF SIRNA AND ANTISENSE OLIGONUCLEOTIDES (SIRNASO) AND METHODS OF USE IN GENE SILENCING

Use of CD56 to predict the differentiation potential of muscle stem cells

METHODS FOR TREATING GLIOBLASTOMA OR RECURRENT GLIOBLASTOMA UTILIZING A WIRELESS SIGNAL ALONE OR IN COMBINATION WITH ONE OR MORE CANCER DRUGS, AND ASSOCIATED SYSTEMS, APPARATUSES, AND DEVICES

NOVEL PEPTIDE-OLIGONUCLEOTIDE CONJUGATE AND USE THEREOF

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

H-1 PV EXPRESSING RNAi EFFECTORS

TRANSMEMBRANE PROTEASE, SERINE 6 (TMPRSS6) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

OLIGONUCLEOTIDES TARGETING S6K1

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

VARIANT RNAi

Non-liposomal systems for nucleic acid delivery

INHIBITION OF FGR REDUCES FIBROSIS

DOUBLE-STRANDED SIRNA HAVING PATTERNED CHEMICAL MODIFICATIONS

CALCIUM VOLTAGE-GATED CHANNEL AUXILIARY SUBUNIT GAMMA 1 (CACNG1) BINDING PROTEINS AND CACNG1-MEDIATED DELIVERY TO SKELETAL MUSCLE

STAUFEN1 AGENTS AND ASSOCIATED METHODS

COMPOSITIONS AND METHODS FOR TREATING HYPERCHOLESTEROLEMIA

FN3 DOMAIN-SIRNA CONJUGATES AND USES THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PCSK9

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

DOSING OF siRNA COMPOUNDS TO THE CISTERNA MAGNA

ANTI-C5 ANTIBODY/C5 IRNA CO-FORMULATIONS AND COMBINATION THERAPIES

DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES

GalNAc compositions for improving siRNA bioavailability

RUNX1 Inhibition for Treatment of Proliferative Vitreoretinopathy and Conditions Associated with Epithelial to Mesenchymal Transition

Skeletal Muscle Delivery Platforms and Methods of Use

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

COMPOSITIONS AND METHODS FOR FIBROBLAST GROWTH FACTOR RECEPTOR 3-MEDIATED DELIVERY TO ASTROCYTES

LOSS OF LIPID KINASE PI5P4K GAMMA RESTRICTS TUMOR GROWTH

CANCER THERAPY

RNAi agents for inhibiting expression of complement component C3 (C3), pharmaceutical compositions thereof, and methods of use

METHODS AND COMPOSITIONS FOR ACCELERATING OLIGODENDROCYTE MATURATION

TEMPLATE DIRECTED IMMUNOMODULATION FOR CANCER THERAPY

METHOD FOR PRODUCING HEMATOPOIETIC CELLS FROM STEM CELLS USING VASCULAR ORGANOIDS

COMPOSITIONS AND METHODS FOR INHIBITION OF CELL-PENETRATING ANTIBODIES

NON-VIRAL GENE/CARRIER COMPLEX FOR PREVENTION OR TREATMENT OF ACUTE INFLAMMATORY DISEASE

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

NUCLEOSIDE CONTAINING siRNAS FOR TREATING VIRAL DISEASES

METHOD OF TREATING FATTY LIVER DISEASE

NUCLEIC ACIDS SIMULTANEOUSLY INHIBITING EXPRESSION OF C-MET GENE AND PD-L1 GENE

METHODS AND COMPOSITIONS USED TO MODIFY CHROMATIN ARCHITECTURE TO REGULATE PHENOTYPE IN AGING AND CANCER

METHODS OF RESTORING FUNCTIONAL CAPACITY AND LINEAGE COMPOSITION OF AN AGING BLOOD AND VASCULAR SYSTEM

METHODS OF DELIVERING ANIONIC AGENTS IN VIVO USING NON-VIRAL NANOPARTICLE-BASED DELIVERY SYSTEMS

A SIRNA DRUG, A PHARMACEUTICAL COMPOSITION, A SIRNA-SMALL MOLECULE DRUG CONJUGATE, AND THE APPLICATION THEREOF

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS FOR THE TREATMENT OF NASH WITH ADVANCED FIBROSIS AND/OR CIRRHOSIS

SUPEROXIDE DISMUTASE 1 (SOD1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING SUPEROXIDE DISMUTASE 1- (SOD1-) ASSOCIATED NEURODEGENERATIVE DISEASES

MULTI-CONJUGATE OF SIRNA AND PREPARING METHOD THEREOF

MODULATING REGULATORY T CELL FUNCTION IN AUTOIMMUNE DISEASE AND CANCER

Lipid formulations for delivery of therapeutic agents

TREATING DISORDERS ASSOCIATED WITH DYRK1A DYSFUNCTION

PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Compositions and methods for organ specific delivery of nucleic acids

VIRAL VECTOR-BASED RNA DELIVERY SYSTEM AND USE THEREOF

GENE CIRCUIT, RNA DELIVERY SYSTEM AND USE THEREOF

SOLUTE CARRIER FAMILY MEMBER IRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR MODULATING PLASMINOGEN

SIRNAS AGAINST KRAS AND RAF1

CHAPERONIN-CONTAINING TCP-1 INHIBITORS FOR THE TREATMENT OF CANCER

ALPHA-1 ANTITRYPSIN (AAT) RNAI AGENTS, COMPOSITIONS INCLUDING AAT RNAI AGENTS, AND METHODS OF USE

ALLELE SELECTIVE INHIBITION OF MUTANT C9ORF72 FOCI EXPRESSION BY DUPLEX RNAS TARGETING THE EXPANDED HEXANUCLEOTIDE REPEAT

RNA DELIVERY SYSTEM FOR TREATMENT OF HUNTINGTON'S DISEASE

CD70-TARGETED MICELLES ENHANCE HIF2? siRNA DELIVERY AND INHIBIT ONCOGENIC FUNCTIONS IN PATIENT-DERIVED CLEAR CELL RENAL CARCINOMA CELLS

RNA PLASMID DELIVERY SYSTEM AND APPLICATION THEREOF

RNA MOLECULE, CHIMERIC NA MOLECULE, DOUBLE-STRANDED RNA MOLECULE, AND DOUBLE-STRANDED CHIMERIC NA MOLECULE

HSD17B13 VARIANTS AND USES THEREOF

MODIFICATION OF IMMUNE CELLS FOR REDUCING TOXICITY AND USES THEREOF IN ADOPTIVE CELL THERAPY

METHODS AND COMPOSITIONS FOR CONTROL OF ARTHROPOD PESTS

TREATMENT AND DIAGNOSIS OF IMMUNE DISORDERS

Factor XII (F12) iRNA compositions and methods of use thereof

GLYCOGEN SYNTHASE KINASE 3 ALPHA (GSK3 ALPHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA

MODIFIED OLIGONUCLEOTIDES TARGETING SNPs

MODULATION OF TRANSTHYRETIN EXPRESSION

TM4SF19 INHIBITOR AND USES THEREOF

METHOD OF TREATMENT OF MALARIA BY TARGETTING OPEN READING FRAMES

METHODS AND COMPOSITIONS FOR REDUCING NUCLEIC ACID VECTOR-INDUCED TOXICITY IN THE INNER EAR

PEPTIDIC BLOCKS FOR NUCLEIC ACID DELIVERY

CATIONIC AMPHIPHILIC POLYMERS FOR CODELIVERY OF HYDROPHOBIC AGENTS AND NUCLEIC ACIDS

PRION PROTEIN (PRNP) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Diagnostic kit for metastasis and invasion of breast cancer and use of shRNA molecule for silencing expression of human LINC01614

RNAI AGENT FOR INHIBITING HBV EXPRESSION AND USE THEREOF

RNA CLEAVAGE-INDUCED TRANSCRIPT STABILIZER AND USES THEREOF

COMPOUNDS FOR TREATMENT OF OSTEOARTHRITIS

Lipid-pegylated compounds, preparations and uses thereof

COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES

METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING PROSTATE CANCER BASED ON LONG NONCODING RNA OVERLAPPING THE LCK GENE THAT REGULATES PROSTATE CANCER CELL GROWTH

LIPOPROTEIN-MIMICKING SOLID LIPID NANOPARTICLES FOR DRUG DELIVERY AND USES THEREOF

COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES

iRNA COMPOSITIONS AND METHODS FOR SILENCING AMYLOID PRECURSOR PROTEIN (APP)

MODIFIED OLIGONUCLEOTIDES

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

A JMJD6 TARGETING AGENT FOR TREATING PROSTATE CANCER

Advanced Cell-Permeable Peptide Carriers

PREVENTION AND/OR TREATMENT OF INFLAMMATORY SKIN DISEASE

METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF 2019-nCoV USING siRNAs AGAINST ORF1AB and N-Protein

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

COMBINATION siRNA AND PEPTIDE DOCKING VEHICLE (PDoV) COMPOSITIONS AND METHODS OF THEIR USE FOR IMPROVED REGULATION AND FUNCTIONALITY

METHODS FOR TREATING AND AMELIORATING CANCER

PRE-IMMUNIZATION AND IMMUNOTHERAPY

METHODS AND COMPOSITIONS RELATED TO T-CELL ACTIVITY

COMPOSITION COMPRISING EMP3 INHIBITOR FOR INHIBITING GROWTH OF CANCER STEMCELL AND USE THEREOF

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF